Search
for
Sort by
Research 181–210 of 1000+
- Index
- Mucocutaneous Manifestations of Endocrine Disorders
- Canine alopecia X
- Androgen treatment in women
- Optimization of menthol-loaded nanocapsules for skin application using the response surface methodology
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- The First Syntheses of 16β-Chloro- and 16β-Bromo-cyproterone Acetate
- Catechins-rich tea extract and its functional properties mitigating hair loss
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Is dehydroepiandrosterone a hormone?
- Serotoninergic and melatoninergic systems are fully expressed in human skin
- Dermatologic manifestations of endocrine disorders
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The therapeutic use of androgens in women
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Toward a Diagnostic Score in Cushing's Syndrome
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Retrospective evaluation of sex hormones and steroid hormone intermediates in dogs with alopecia
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Diagnostic approach to low‐renin hypertension
- Management of CAH during pregnancy
- An update of the pathogenesis of frontal fibrosing alopecia: What does the current evidence tell us?
- Frontiers in the (Neuro-)endocrine Controls of Hair Growth